about
Distinct effects of calorie restriction and exercise on mammary gland gene expression in C57BL/6 miceClostridium perfringens enterotoxin interacts with claudins via electrostatic attraction.Genomic profiling of tumor initiating prostatospheres.Inhibition of telomerase activity alters tight junction protein expression and induces transendothelial migration of HIV-1-infected cells.Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency.A novel screening system for claudin binder using baculoviral display.Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasionClaudin 1 mediates TNFα-induced gene expression and cell migration in human lung carcinoma cells.The effects of claudin 14 during early Wallerian degeneration after sciatic nerve injury.Specificity of interaction between clostridium perfringens enterotoxin and claudin-family tight junction proteinsTight junction proteins claudin-3 and claudin-4 control tumor growth and metastasesClaudin-6: a novel receptor for CPE-mediated cytotoxicity in ovarian cancerClaudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformationClaudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancersThe claudin family of proteins in human malignancy: a clinical perspectiveTight junction-based epithelial microenvironment and cell proliferation.Truncation of histone H2A's C-terminal tail, as is typical for Ni(II)-assisted specific peptide bond hydrolysis, has gene expression altering effectsRegulation and roles for claudin-family tight junction proteinsThe sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors.Proof of concept for claudin-targeted drug development.Trends in drug delivery through tissue barriers containing tight junctions.Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers.Expression of Tight Junction Components in Hepatocyte-Like Cells Differentiated from Human Embryonic Stem Cells.Claudin 1 mediates tumor necrosis factor alpha-induced cell migration in human gastric cancer cells.The role of claudins in cancer metastasis.Inhibition of matrix metalloproteinase activities and tightening of tight junctions by diallyl disulfide in AGS human gastric carcinoma cells.Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma.Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.Cycling hypoxia affects cell invasion and proliferation through direct regulation of claudin1 / claudin7 expression, and indirect regulation of P18 through claudin7.Developmental lung expression and transcriptional regulation of claudin-6 by TTF-1, Gata-6, and FoxA2.Homo- and heterotypic cell-cell contacts in Merkel cells and Merkel cell carcinomas: heterogeneity and indications for cadherin switching.Activation mechanism of claudin-4 by ephrin type-A receptor 2: a molecular dynamics approach.High expression of claudin-1 protein in papillary thyroid tumor and its regional lymph node metastasis.Claudin-1 expression in cervical cancer.RETRACTED: Differences in the expression profiles of claudin proteins in human nasopharyngeal carcinoma compared with non-neoplastic mucosa.Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma.CLDN2 inhibits the metastasis of osteosarcoma cells via down-regulating the afadin/ERK signaling pathway
P2860
Q33559325-0EC95AC8-83F7-45E6-B2DD-0B9E4E4D3FBAQ33581317-71EE182A-8F23-48EE-ACA6-364217735274Q33586722-274B61B9-9235-4567-8798-7411A61E0068Q33784426-C6C0A54E-5C89-4628-885E-5067CF4AF57AQ33814933-FF8C23B4-DF6C-4BD1-B228-907EA398E418Q33826108-44A2D76A-698E-4C77-8E43-1F4F316A7E26Q33971294-3F6A0930-C0CA-423E-9537-E47DDB834435Q34295450-135DDE2B-DC26-4DAA-A5BB-E3BCD258A30AQ35046936-67719C07-46FB-4DCB-A6E9-24969CD560BCQ35155903-323D980F-DDF3-4302-AE01-A360EEFB53EBQ36343793-BEC8000E-7041-410B-A037-B009F721A879Q36438309-73A7E2F5-8DF2-4576-9012-A259C629E136Q36982054-51245F87-E1F8-42E6-A8DF-28549BBE192AQ37066104-30E7510B-A89F-41C6-8A48-16184B6ACC3EQ37302556-6D9A6C7E-3C44-4460-AFBA-B98FAC580FDFQ37333599-FEC42EFC-F484-4990-B380-03D52D3465A3Q37409379-CBC5DA03-E2E6-4628-BA2B-F783795B9205Q37423257-1C453ECE-A638-4869-9235-602A0FB8DC50Q37800462-9910BB3B-A935-43B5-9012-E3241B9FA9F9Q38021496-42740C69-4664-4BDE-A7BE-767C37EEC597Q38199103-7FF27B3E-F6CF-4993-B25C-355272781BE2Q38821198-77871B9C-4D3C-4BE1-8C54-921336C0B1B7Q38890621-6FB29A9C-FF22-4501-B444-BC8571DD015CQ38924540-5364BC39-9FD6-4B92-A54C-68A8E58CDB9EQ38927656-ECD07BED-3C4D-48AE-BB99-39D4696F9D30Q39379865-3BD7C197-B562-4785-99C0-FC8B7204023AQ39489740-3D0B6C89-A160-4C5A-AD8F-5770A418C07FQ39527898-48480EE1-5BEC-4A74-A8FE-56C35C2A0E0CQ42259799-1250667D-9CB0-4A9C-9FF3-3866A5AACE4DQ42721446-08554DF6-7DC7-46AF-8CED-BE8E54D015F1Q43635769-5CE22110-0933-4C58-A7F4-3EE37B824139Q44907481-9C174618-CD1F-4346-AB3F-95B69206A25FQ46778463-428D1DA3-A4BE-4D57-8393-9A5E66AA0015Q47098613-78EB490C-7AF7-4398-8B8F-D679BA3887B7Q49308998-010E79A9-E659-4368-9E52-D0AD81099194Q51625972-EF5A5064-45E7-4CFB-BFAF-E4BDAA8C0F0FQ57813171-B9751571-B849-4B6C-A5EB-69985B8EA2B1
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Claudins: emerging targets for cancer therapy.
@ast
Claudins: emerging targets for cancer therapy.
@en
type
label
Claudins: emerging targets for cancer therapy.
@ast
Claudins: emerging targets for cancer therapy.
@en
prefLabel
Claudins: emerging targets for cancer therapy.
@ast
Claudins: emerging targets for cancer therapy.
@en
P1476
Claudins: emerging targets for cancer therapy.
@en
P2093
Scott L Kominsky
P356
10.1017/S1462399406000056
P577
2006-08-04T00:00:00Z